Drugs / Rabbit anti-human thymocyte immunoglobulin
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT07519005 Background | Jan → Feb 2026 overdue | liver failure | Xijing Hospital | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Rabbit anti-human thymocyte immunoglobulin | “Rabbit anti-human thymocyte immunoglobulin (ATG, 1-1.5 mg/kg/day for 2-3 days)” NCT07519005 ↗ |
| Known as | ATG | “Rabbit anti-human thymocyte immunoglobulin (ATG, 1-1.5 mg/kg/day for 2-3 days)” NCT07519005 ↗ |